Page 563 - Read Online

Puckett et al. J Cancer Metastasis Treat 2020;6:11 I http://dx.doi.org/10.20517/2394-4722.2020.98 Page 7 of 8

DECLARATIONS
Authors’ contributions
Made substantial contributions to conception and design of the literature review: Puckett Y, Pawlik TM
Performed literature review and manuscript preparation: Puckett Y, Eskander MF, Aquina CT
Responsible for conception and design of literature review: Pawlik TM

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30.
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
3. Nentwich MF, Bockhorn M, Konig A, Izbicki JR, Cataldegirmen G. Surgery for advanced and metastatic pancreatic cancer--current state
and trends. Anticancer Res 2012;32:1999-2002.
4. Mann O, Strate T, Schneider C, Yekebas EF, Izbicki JR. Surgery for advanced and metastatic pancreatic cancer--current state and
perspectives. Anticancer Res 2006;26:681-6.
5. Treasure T. Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity? J R Soc Med 2012;105:242-6.
6. Damanakis AI, Ostertag L, Waldschmidt D, et al. Proposal for a definition of “Oligometastatic disease in pancreatic cancer”. BMC Cancer
2019;19:1261.
7. Lu F, Poruk KE, Weiss MJ. Surgery for oligometastasis of pancreatic cancer. Chin J Cancer Res 2015;27:358-67.
8. Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in
Oncology. J Natl Compr Canc Netw 2017;15:1028-61.
9. Hackert T, Niesen W, Hinz U, et al. Radical surgery of oligometastatic pancreatic cancer. Eur J Surg Oncol 2017;43:358-63.
10. Michalski CW, Erkan M, Huser N, Muller MW, Hartel M, Friess H, Kleeff J. Resection of primary pancreatic cancer and liver metastasis:
a systematic review. Dig Surg 2008;25:473-80.
11. Bockhorn M, Cataldegirmen G, Kutup A, et al. Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status.
Impact of “desmoplastic pseudo-pancreatitis” and anatomical site of irresectability. Ann Surg Oncol 2009;16:1212-21.
12. D’Haese JG, Renz BW, Ilmer M, Werner J. Surgery for isolated local recurrence and metachronous oligometastasis in pancreatic cancer.
Chirurg 2020;91:628-35.
13. Yamamoto S, Sato Y, Takeishi T, et al. Liver transplantation in an endostage cirrhosis patient with abdominal compartment syndrome
following a spontaneous rectus sheath hematoma. J Gastroenterol Hepatol 2004;19:118-9.
14. Van Oudheusden TR, Grull H, Dankers PY, De Hingh IH. Targeting the peritoneum with novel drug delivery systems in peritoneal
carcinomatosis: a review of the literature. Anticancer Res 2015;35:627-34.
15. Sugarbaker PH. Strategies to improve local control of resected pancreas adenocarcinoma. Surg Oncol 2017;26:63-70.
16. Staribratova D, Zaprianov Z, Uchikov A. Adenocarcinoma of the pancreas with distant meningeal metastasis. Khirurgiia (Sofiia) 2009:48-
51.
17. Maeno T, Satoh H, Ishikawa H, et al. Patterns of pancreatic metastasis from lung cancer. Anticancer Res 1998;18:2881-4.
18. Kocic M, Nikolic S, Zegarac M, et al. Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic
intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience. J BUON 2016;21:1176-